
Catherine Sazdanoff
Catherine is a board member and consultant with extensive global healthcare experience. She is an independent director of the Board of Meridian Bioscience, Inc. (NASDAQ: VIVO) and of Vascugen, Inc.
The mission of DirectWomen is to increase the representation of women lawyers on corporate boards.
In order to conduct its various programs, DirectWomen relies on the support of corporate and law firm sponsorships, as well as individual donations. Join the coalition of leading companies, AmLaw 100 law firms, and individual donors that reinforce their commitment to good corporate governance by supporting DirectWomen.
Click here to view the different sponsor levels.
If you are interested in sponsoring, please contact Executive Director Shawn Taylor Kaminski (skaminski@directwomen.org) or call DirectWomen at (833) 239-6636.
DirectWomen’s network includes more than:
Nearly forty percent (40%) of DirectWomen alumnae have been elected to serve on at least one corporate board.
DirectWomen is an independent 501(c)(3) organization. Contributions to DirectWomen are tax-deductible to the full extent allowed by the law.
Catherine is a board member and consultant with extensive global healthcare experience. She is an independent director of the Board of Meridian Bioscience, Inc. (NASDAQ: VIVO) and of Vascugen, Inc.
Aleks Miziolek is an experienced public company director and C-Suite leader having most recently served as the Chief Transformation Officer, General Counsel, Corporate Secretary and Chief Compliance Officer for Cooper-Standard
C. Kay McCall is a senior energy executive with broad industry expertise, including strategy, project development, operations, acquisitions, and governance. In addition to more than a decade of experience in